NRX Pharmaceuticals, Inc. (NRXP)

Price$3.44Cached quote
NRXPNasdaq
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

8 annual periodsNewest to oldest
20252024202320222021202020192018
Revenue$1.2M$0$0$0————
Gross profit$720,000$0——————
Gross margin58.78%———————
Research & development$3.8M$6.2M$13.4M$17.0M$20.3M$10.6M——
Operating expenses$17.4M$18.5M$27.8M$44.3M$115.8M$51.4M$713,187$1.0M
Operating income−$16.2M−$18.5M−$27.8M−$44.3M−$115.8M−$51.4M−$713,187−$1.0M
Operating margin−1,324.41%———————
EBITDA−$16.2M−$18.5M−$27.8M−$44.3M−$115.8M−$51.4M——
EBITDA margin−1,318.69%———————
Net income−$28.6M−$25.1M−$30.1M−$39.8M−$93.1M−$51.8M$408,427$66,101
Net profit margin−2,336.49%———————
Basic EPSper basic share-$1.34-$2.36-$3.98-$0.60-$19.80-$15.10-$0.07-$0.18
Diluted EPSper diluted share-$1.34-$2.36-$3.98-$6.00-$19.80-$15.10-$0.07-$0.18

Owners

Reported shareholders

Reference date Jun 30, 2026
B Group, Inc. · 9.48% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 3.75% of listed sharesJavitt Jonathan C · ≈3.51% of listed sharesAMERIPRISE FINANCIAL INC · 2.15% of listed sharesBalyasny Asset Management L.P. · 2.07% of listed sharesCITADEL ADVISORS LLC · 1.58% of listed sharesAdvisorShares Investments LLC · 1.53% of listed sharesCOMMONWEALTH EQUITY SERVICES, LLC · 1.05% of listed sharesUBS Group AG · 0.98% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 0.73% of listed sharesBlackRock, Inc. · 0.51% of listed sharesMARSHALL WACE, LLP · 0.45% of listed sharesVANGUARD FIDUCIARY TRUST CO · 0.42% of listed sharesJANE STREET GROUP, LLC · 0.28% of listed sharesBleakley Financial Group, LLC · 0.27% of listed sharesSTATE STREET CORP · 0.27% of listed sharesHRT FINANCIAL LP · 0.23% of listed sharesNORTHERN TRUST CORP · 0.15% of listed sharesChicago Partners Investment Group LLC · 0.11% of listed sharesQuadrature Capital Ltd · 0.10% of listed shares
9.48%of listed shares
B Group, Inc.4.09M shares · Jun 30, 2026
View holders
Top 20 reported holders of NRXP
Holder% owned
B Group, Inc.
9.48%4.09M shares
VANGUARD CAPITAL MANAGEMENT LLC
3.75%1.62M shares
Javitt Jonathan C
≈3.51%1.52M shares
AMERIPRISE FINANCIAL INC
2.15%928.73K shares
Balyasny Asset Management L.P.
2.07%893.86K shares
CITADEL ADVISORS LLC
1.58%680.04K shares
AdvisorShares Investments LLC
1.53%659.02K shares
COMMONWEALTH EQUITY SERVICES, LLC
1.05%454.42K shares
UBS Group AG
0.98%423.12K shares
GEODE CAPITAL MANAGEMENT, LLC
0.73%314.66K shares
BlackRock, Inc.
0.51%220.46K shares
MARSHALL WACE, LLP
0.45%194.58K shares
VANGUARD FIDUCIARY TRUST CO
0.42%182.72K shares
JANE STREET GROUP, LLC
0.28%119.02K shares
Bleakley Financial Group, LLC
0.27%117.22K shares
STATE STREET CORP
0.27%116.08K shares
HRT FINANCIAL LP
0.23%100.72K shares
NORTHERN TRUST CORP
0.15%62.95K shares
Chicago Partners Investment Group LLC
0.11%46.39K shares
Quadrature Capital Ltd
0.10%43.61K shares

Percentages use 43.16M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys1$46.8K disclosed value
Sells (SEC code S)0$0.00 disclosed value
1 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 17, 2024Form 4Javitt Jonathan CChairman and Chief ScientistBuyCommon Stock40.0K$1.17$46.8K84.6K

Community posts

It’s quiet here.

No posts about NRXP yet. Start the conversation.

Write the first post